Follow-up Safety Data Show AFREZZA[TM] Comparable to Standard Antidiabetic Therapy in Lung Function Tests.
Business Wire › April 23, 2010
Linked as:
Extract
Follow-up Safety Data Show AFREZZA[TM] Comparable to Standard Antidiabetic Therapy in Lung Function Tests.
Follow-up Study with Investigational Diabetes Therapy Presented at the American Association of Clinical Endocrinologists 19(th) Annual Meeting
BOSTON -- Pulmonary function test results (PFTs) in patients treated with AFREZZA(TM) (insulin human [rDNA origin]) Inhalation Powder, a well-...See the full content of this document
Sponsored links
